Heritability of lifetime ecstasy use

Area of Science:

• Psychiatry
• Behavioral Genetics
• Addiction Research

Background:

• Ecstasy (MDMA) is a popular psychoactive drug known for its euphoric and social effects.
• Despite perceived benefits, ecstasy use carries significant immediate and long-term health risks.
• Previous research suggested genetic factors influence ecstasy use, but heritability remained undetermined.

Purpose of the Study:

• To estimate the heritability of lifetime ecstasy use.
• To quantify the contributions of genetic, shared environmental, and residual factors to ecstasy use liability.

Main Methods:

• Utilized a classical twin design with a large sample of 8500 twins and siblings (aged 18-45) from the Netherlands Twin Registry.
• Collected data via questionnaires in 2013-2014, assessing lifetime ecstasy use.
• Applied statistical modeling to partition variance in ecstasy use liability.

Main Results:

• 10.4% of the sample reported lifetime ecstasy use, with slightly higher prevalence in males.
• Genetic differences accounted for 74% of the liability to lifetime ecstasy use.
• Shared environmental and residual factors explained 5% and 21% of liability, respectively.

Conclusions:

• Lifetime ecstasy use is a highly heritable trait.
• Genetic vulnerability plays a significant role in an individual's likelihood of initiating ecstasy use.
• Findings highlight the importance of genetic factors in understanding patterns of drug use.